NAS:RTIX (USA) Also trade in: Germany

RTI Surgical Holdings Inc

$ 4.39 -0.02 (-0.45%)
On watch
Volume: 15,652 Avg Vol (1m): 263,182
Market Cap $: 328.10 Mil Enterprise Value $: 551.94 Mil
P/E (TTM): 0.00 P/B: 1.25
Earnings Power Value 0.13
Net Current Asset Value -3.07
Tangible Book -1.49
Projected FCF 2.23
Median P/S Value 4.5
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 5/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.04
Cash-To-Debt ranked lower than
76.06% of 330 companies
in the Medical Devices industry.
Industry Max: 504099, Med: 2.32, Min: -16.34
RTIX: 0.04
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.04, Med: 1.16, Max: 1459
Current: 0.04
0.04
1459
Equity-to-Asset 0.49
Equity-to-Asset ranked lower than
65.70% of 309 companies
in the Medical Devices industry.
Industry Max: 0.99, Med: 0.63, Min: -24.4
RTIX: 0.49
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: 0.3, Med: 0.7, Max: 0.9
Current: 0.49
0.3
0.9
Debt-to-Equity 0.54
Debt-to-Equity ranked higher than
55.00% of 220 companies
in the Medical Devices industry.
Industry Max: 11.69, Med: 0.3, Min: 0.01
RTIX: 0.54
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: 0, Med: 0.1, Max: 0.54
Current: 0.54
0
0.54
Debt-to-EBITDA 35.07
Debt-to-EBITDA ranked higher than
64.56% of 158 companies
in the Medical Devices industry.
Industry Max: 3384.46, Med: 1.98, Min: 0.02
RTIX: 35.07
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: -4.27, Med: 1, Max: 118.22
Current: 35.07
-4.27
118.22
Interest Coverage 1.81
Interest Coverage ranked lower than
75.00% of 212 companies
in the Medical Devices industry.
Industry Max: 10000, Med: 66.37, Min: 0.03
RTIX: 1.81
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 1.81, Med: 13.61, Max: 58.56
Current: 1.81
1.81
58.56
Piotroski F-Score 4
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.72
DISTRESS
GREY
SAFE
Beneish M-Score -1.82
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 1.57%
WACC 8.67%

Profitability & Growth : 5/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 2.28
Operating Margin ranked higher than
70.51% of 312 companies
in the Medical Devices industry.
Industry Max: 1148.46, Med: 1.96, Min: -47867.72
RTIX: 2.28
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: -8.47, Med: 4.22, Max: 9.36
Current: 2.28
-8.47
9.36
Net Margin % -3.34
Net Margin ranked higher than
52.56% of 312 companies
in the Medical Devices industry.
Industry Max: 15538.12, Med: 1.4, Min: -45900
RTIX: -3.34
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -77.87, Med: 1.64, Max: 5.28
Current: -3.34
-77.87
5.28
ROE % -4.82
ROE ranked higher than
51.32% of 304 companies
in the Medical Devices industry.
Industry Max: 51.97, Med: 0.95, Min: -2921.66
RTIX: -4.82
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: -57.28, Med: 0.5, Max: 6.65
Current: -4.82
-57.28
6.65
ROA % -2.29
ROA ranked higher than
56.63% of 332 companies
in the Medical Devices industry.
Industry Max: 1204.95, Med: -0.26, Min: -2520.55
RTIX: -2.29
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -44.6, Med: 1.21, Max: 3.93
Current: -2.29
-44.6
3.93
ROC (Joel Greenblatt) % -5.30
ROC (Joel Greenblatt) ranked higher than
62.69% of 327 companies
in the Medical Devices industry.
Industry Max: 8175, Med: 3.87, Min: -323166.67
RTIX: -5.3
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -87.77, Med: 4.73, Max: 15.26
Current: -5.3
-87.77
15.26
3-Year Total Revenue Growth Rate -0.20
3-Year Revenue Growth Rate ranked lower than
63.39% of 254 companies
in the Medical Devices industry.
Industry Max: 300.7, Med: 4.3, Min: -100
RTIX: -2.8
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -22.6, Med: 1.5, Max: 14.9
Current: -2.8
-22.6
14.9
3-Year Total EBITDA Growth Rate -34.20
3-Year EBITDA Growth Rate ranked higher than
73.28% of 232 companies
in the Medical Devices industry.
Industry Max: 109.5, Med: 7.5, Min: -344.2
RTIX: -35.9
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
N/A

» RTIX's 30-Y Financials

Financials (Next Earnings Date: 2019-08-02)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:RTIX

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Devices » Medical Devices    NAICS : 339113    SIC : 3842
Compare SZSE:300314 ROCO:4736 NAS:SIBN HKSE:06118 NAS:ARAY NAS:GNMK MIL:ELN XTER:EUZ AMEX:CVRS SZSE:300562 OSTO:XVIVO XKRX:043150 HKSE:01858 NAS:IRMD NAS:ACRX NYSE:VAPO XTAE:INCR LSE:CREO ASX:AVH OTCPK:SMLR
Traded in other countries RT2.Germany
Address 11621 Research Circle, Alachua, FL, USA, 32615
RTI Surgical Inc produces orthopedic and surgical implants that repair human bone and tissues. The firm sells products in six categories: spine, ortho fixation, sports medicine, bone graft substitutes (BGS) and general orthopedic, dental, and surgical specialties. The spine category contributes the maximum proportion of revenue and includes spine allografts, rods, and plates. The ortho fixation segment sells instruments and implants for the trauma and cardio thoracic markets. RTI's sports medicine products include allograft implants for sports-related injuries. The BGS business sells bone graft substitutes and allograft paste implants. RTI generates the vast majority of its revenue in the United States.

Ratios

Current vs industry vs history
PB Ratio 1.25
PB Ratio ranked higher than
55.48% of 310 companies
in the Medical Devices industry.
Industry Max: 1180, Med: 3.06, Min: 0.07
RTIX: 1.25
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 0.27, Med: 1.25, Max: 2.41
Current: 1.25
0.27
2.41
PS Ratio 1.02
PS Ratio ranked higher than
78.91% of 294 companies
in the Medical Devices industry.
Industry Max: 1136.36, Med: 3.15, Min: 0.05
RTIX: 1.02
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 0.54, Med: 1.08, Max: 3.28
Current: 1.02
0.54
3.28
Price-to-Operating-Cash-Flow 100.90
Price-to-Operating-Cash-Flow ranked lower than
87.40% of 127 companies
in the Medical Devices industry.
Industry Max: 1586.78, Med: 20.01, Min: 3.03
RTIX: 100.9
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 3.57, Med: 25.07, Max: 924
Current: 100.9
3.57
924
EV-to-EBIT -55.13
EV-to-EBIT ranked higher than
75.29% of 174 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 24.76, Min: 0.63
RTIX: -55.13
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: -145.9, Med: 11.9, Max: 813.1
Current: -55.13
-145.9
813.1
EV-to-EBITDA 118.30
EV-to-EBITDA ranked higher than
82.45% of 188 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 18.14, Min: 0.62
RTIX: 118.3
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: -123.4, Med: 8.3, Max: 396.9
Current: 118.3
-123.4
396.9
EV-to-Revenue 1.98
EV-to-Revenue ranked higher than
79.29% of 309 companies
in the Medical Devices industry.
Industry Max: 17078.6, Med: 3.73, Min: 0.05
RTIX: 1.98
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 0.6, Med: 1.2, Max: 4.6
Current: 1.98
0.6
4.6
Current Ratio 3.50
Current Ratio ranked higher than
62.04% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.71, Min: 0.03
RTIX: 3.5
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 1, Med: 3.57, Max: 5.91
Current: 3.5
1
5.91
Quick Ratio 1.35
Quick Ratio ranked lower than
69.44% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.03, Min: 0.02
RTIX: 1.35
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.49, Med: 1.53, Max: 3.07
Current: 1.35
0.49
3.07
Days Inventory 285.78
Days Inventory ranked lower than
82.31% of 294 companies
in the Medical Devices industry.
Industry Max: 990.33, Med: 143.61, Min: 0.63
RTIX: 285.78
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 282.77, Med: 310.14, Max: 366.78
Current: 285.78
282.77
366.78
Days Sales Outstanding 72.39
Days Sales Outstanding ranked higher than
84.06% of 276 companies
in the Medical Devices industry.
Industry Max: 907.73, Med: 69.21, Min: 0.13
RTIX: 72.39
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 44.21, Med: 51.62, Max: 72.39
Current: 72.39
44.21
72.39
Days Payable 62.45
Days Payable ranked lower than
57.47% of 261 companies
in the Medical Devices industry.
Industry Max: 912.5, Med: 58.34, Min: 1
RTIX: 62.45
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 44.15, Med: 62.07, Max: 83.22
Current: 62.45
44.15
83.22

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -2.50
3-Year Share Buyback Rate ranked higher than
61.07% of 244 companies
in the Medical Devices industry.
Industry Max: 19.2, Med: -5.7, Min: -1393.3
RTIX: -2.5
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -22.4, Med: -3.9, Max: -0.8
Current: -2.5
-22.4
-0.8

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 1.99
Price-to-Intrinsic-Value-Projected-FCF ranked lower than
78.51% of 121 companies
in the Medical Devices industry.
Industry Max: 89.64, Med: 2.44, Min: 0.43
RTIX: 1.99
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.82, Med: 1.68, Max: 91.43
Current: 1.99
0.82
91.43
Price-to-Median-PS-Value 0.99
Price-to-Median-PS-Value ranked higher than
56.12% of 237 companies
in the Medical Devices industry.
Industry Max: 20.13, Med: 1.02, Min: 0.02
RTIX: 0.99
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.61, Med: 1.23, Max: 3.8
Current: 0.99
0.61
3.8
Earnings Yield (Joel Greenblatt) % -1.86
Earnings Yield (Greenblatt) ranked higher than
87.35% of 332 companies
in the Medical Devices industry.
Industry Max: 158.73, Med: 0.74, Min: -2500
RTIX: -1.86
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: -117.3, Med: 1.9, Max: 10.1
Current: -1.86
-117.3
10.1

More Statistics

Revenue (TTM) (Mil) $ 280.71
EPS (TTM) $ -0.17
Beta 1.22
Volatility % 36.59
52-Week Range $ 3.51 - 6.15
Shares Outstanding (Mil) 73.9

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 4
Positive ROA N
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y